![1]()
News
AFib patients do best on a DOAC started 7-10 days post stroke
March 4, 2020
LOS ANGELES – Observational data hints at the best time to start oral anticoagulation in AFib patients after a cardioembolic stroke.
![1]()
News
CDC: Opioid prescribing and use rates down since 2010
January 31, 2020
Encouragement from analysis involving 11 states is offset by increase in opioid-attributable deaths.
![1]()
News
Zika virus: Birth defects rose fourfold in U.S. hardest-hit areas
January 27, 2020
U.S. jurisdictions without local transmission of the virus saw no increase in infants born with brain abnormalities and/or microcephaly or with eye abnormalities.
![1]()
News
FDA advisers set high bar for new opioids
January 21, 2020
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
![1]()
News
Treating pain with virtual reality
January 7, 2020
It offers more than just distraction.
![1]()
News
Experts call to revise the Uniform Determination of Death Act
January 3, 2020
A neurologist and her colleagues propose changes with the goal of clarifying and harmonizing procedures for determining death by neurologic criteria.
![1]()
News
A novel communication framework for inpatient pain management
December 20, 2019
Spend adequate time to fully visit the patients’ history as it relates to their current pain complaints.
![1]()
News
FDA warns gabapentin, pregabalin may cause serious breathing problems
December 19, 2019
The drugs increase the risk of respiratory depression when used with central nervous system depressants or in patients with lung problems, according to a Dec. 19 drug safety alert.
![1]()
News
Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations
December 11, 2019
BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.
![1]()
News
Genetic test stratified AFib patients with low CHA2DS2-VASc scores
December 9, 2019
A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.
